Strategies for Biotech/Medtech Startups: Successfully Navigating the USPTO and FDA

Hear industry professionals and government officials from the U.S. Patent and Trademark Office (USPTO) and U.S. Food and Drug Administration (FDA) discuss the intricacies biotech/medtech independent inventors and startups face when securing Intellectual Property (IP) rights from the USPTO and seeking regulatory approval from the FDA.

Topics:

Navigating USPTO patent and FDA regulatory processes with an emphasis on biotech and medtech industries
Sharing initiatives, strategies, tips, and best practices to protect your discoveries and innovations

Speakers:

Linda Horner, USPTO – Administrative Patent Judge, Patent Trial and Appeal Board (PTAB)
Brandon Fetterolf, USPTO – Director (acting), TC 1600 Biotechnology and Organic Chemistry
Jonathan Teixeira Moffat, USPTO – Director, TC 3700 Medical Devices and Processes
Kevin Bugin, Ph.D., FDA – Deputy Director for Operations, CDER/Office of New Drugs
Barbara Zimmerman, FDA – Deputy Office Director, CDRH/Center for Devices and Radiological Health
Tom Cowan, Knobbe Martens – Partner
Kimberly Miller, Knobbe Martens – Partner
And more…

REGISTER

*A meeting link will be sent to registered attendees the week of the event.

This event is in collaboration with the U.S. Patent and Trademark Office (USPTO), U.S. Food and Drug Administration (FDA), and Biocom California.

California MCLE credit will be offered.

Questions? Contact the Silicon Valley Regional USPTO via email siliconvalley@uspto.gov or call 408-918-9900.

To request a reasonable accommodation, including captioning, sign language interpreting, or other, please email siliconvalley@uspto.gov or call 408-918-9900.